WASHINGTON (AP) — A blood test may predict if apparently healthy older adults are likely to develop Alzheimer’s symptoms in the next five or 1…
From
To
FILE - A human brain affected by Alzheimer's disease is displayed at the Museum of Neuroanatomy at the University at Buffalo in Buffalo, N.Y., on Oct. 7, 2003. (AP Photo/David Duprey, File)
An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau. Today two Alzheimer's drugs can modestly slow cognitive decline by clearing away buildup of a different protein, amyloid. But tau plays a role, too, and there are no tau-targeting drugs. Researchers at the Alzheimer's Association International Conference reported new findings Tuesday suggesting Biogen's experimental drug diranersen also might offer that benefit. The company plans a larger study to tell. It's one of multiple novel, but early-stage, attempts to fight the mind-robbing disease.
These brain scan images provided by Biogen show how high levels of Alzheimer's-related tau protein, in red, dropped in a recipient of the company's experimental drug diranersen. (Biogen via AP)
AP
LONDON (AP) — British brothers Jordan and Cian Adams made sure to bring back little mementos from their day sitting among the VIPs at Wimbledon.
Featured Top Story
A community event will bring people together for dementia awareness and connection this summer.
Featured Top Story
Country music star is teaming up to fight against Alzheimer's and dementia.
Featured Top Story
Reno Police say an elderly man who was reported missing earlier this week has been found and returned home.
Featured Top Story
A free seminar at the Reno-Sparks Convention Center seeks to shed light on dementia.
Featured Top Story
The FDA approved a similar drug, Leqembi, from a Japanese drugmaker last year.